Viewing StudyNCT03406000



Ignite Creation Date: 2024-05-06 @ 11:00 AM
Last Modification Date: 2024-10-26 @ 12:38 PM
Study NCT ID: NCT03406000
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2018-01-15

Brief Title: Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 UmL
Sponsor: Sanofi
Organization: Sanofi

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-01-22
Start Date Type: ACTUAL
Primary Completion Date: 2019-02-04
Primary Completion Date Type: ACTUAL
Completion Date: 2019-02-04
Completion Date Type: ACTUAL
First Submit Date: 2018-01-15
First Submit QC Date: January 19 2018
Study First Post Date: 2018-01-23
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-04-21
Last Update Post Date: 2022-04-25
Last Update Post Date Type: ACTUAL